EMD Serono Unveils New MAVENCLAD ® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity

Sep 13, 2024 - 00:00
EMD Serono Unveils New MAVENCLAD ® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow